Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention

American Journal of Cardiology

Volumn 86, Issue 6, 2000, Pages 619-622

  Kanaparti, Praveen K ^a   Brown, David L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 0034665710     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01039-0     Document Type: Article

References (18)

1. Klein L., Kramer B., Howard E., Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q-wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol. 17:1991;621-626.
2. Kugelmass A.D., Cohen D.J., Moscucci M., Piana R.N., Cenerchia C., Kuntz R.E., Baim D.S. Elevation of creatine kinase isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol. 74:1994;748-754.
3. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 330:1994;956-961.
4. Abdelmeguid A.E., Whitlow P.L., Sapp S.K., Ellis S.G., Topol E.J. Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure. Circulation. 91:1995;2733-2741.
5. Abdelmeguid A.E., Topol E.J., Whitlow P.L., Sapp S.K., Ellis S.G. Significance of mild transient release of creatine kinase MB fraction after percutaneous coronary interventions. Circulation. 94:1996;1528-1536.
6. Abdelmeguid A.E., Ellis S.G., Sapp S.K., Whitlow P.L., Topol E.J. Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. Am Heart J. 131:1996;1097-1105.
7. Kong T.Q., Davidson C.J., Meyers S.N., Parker M.A., Bonow R.O. Prognostic implications of creatine kinase elevation following elective coronary interventions. JAMA. 277:1997;461-466.
8. Tardiff B.E., Califf R.M., Tcheng J.E., Lincoff A.M., Sigmon K.N., Harrington R.A., Mahaffey K.W., Ohman E.M., Teirstein P.S., Blankenship J.C., Kitt M.M., Topol E.J. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol. 33:1999;88-96.
9. Harrington R.A., Lincoff A.M., Califf R.M., Holmes D.R. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention insights from the coronary angioplasty versus excisional atherectomy trial (CAVEAT) . J Am Coll Cardiol. 25:1995;1693-1699.
10. Austen W.G., Edwards J.E., Frye R.L., Gensini G.G., Gott V.L., Griffith L.S.C., McGoon D.C., Murphy M.L., Roc B.B. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 51:(suppl):1975;5-40.
11. Sullivan D.R., Marwick T.H., Freedman S.B. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J. 119:1990;1262-1267.
12. Nakagomi A., Celermajer D.S., Lumley T., Freedman S.B. Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis. Am J Cardiol. 78:1996;516-519.
13. Proudfit W.J., Bruschke A.V.G., MacMillan J.P., Williams G.W., Sones F.M. Jr. Fifteen-year survival study of patients with obstructive coronary artery disease. Circulation. 68:1983;986-997.
14. Little W.C., Contantinescu M., Applegate R.J., Kutcher M.A., Burrows M.T., Kahl F.R., Santamore W.P. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 78:1988;1157-1166.
15. Ellis S.G., Popma J.J., Buchbinder M., Franco I., Leon M.B., Kent K.M., Pichard A.D., Satler L.F., Topol E.J., Whitlow P.L. Relation of clinical presentation, stenosis morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty. Circulation. 89:1994;882-892.
16. Kini A., Marmur J.D., Kini S., Dangas G., Cocke T.P., Wallenstein S., Brown E., Ambrose J.A., Sharma S.K. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course implications for early discharge after coronary intervention . J Am Coll Cardiol. 34:1999;663-671.
17. Grundy S.M. Primary prevention of coronary heart disease integrating risk assessment with intervention . Circulation. 100:1999;988-998.
18. Mehran R., Dangas G., Mintz G.S., Lansky A.J., Pichard A.D., Satler L.F., Kent K.M., Stone G.W., Leon M.B. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions intravascular ultrasound study of 2256 patients . Circulation. 101:2000;604-610.